Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study.
about
Left Ventricular Assist Devices for Destination Therapy: A Health Technology AssessmentEthics in the treatment of advanced heart failure: palliative care and end-of-life issues.Biocompatibility assessment of the first generation PediaFlow pediatric ventricular assist deviceSurvival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients.Ventricular assist devices: is destination therapy a viable alternative in the non-transplant candidate?Ventricular-assist devices for the treatment of chronic heart failure.Development of a Double-Lumen Cannula for a Percutaneous RVAD.Current status of mechanical circulatory assistance.Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device.Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries.Cost-effectiveness of left ventricular-assist devices in end-stage heart failure.Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation.The spectrum of complications following left ventricular assist device placement.Destination therapy: the new gold standard treatment for heart failure patients with left ventricular assist devices.Left ventricular assist devices in patients with end-stage heart failure: suggestion of an alternative treatment based on clinically well-known concepts.The Evolution of a Pediatric Ventricular Assist Device Program: The Boston Children's Hospital Experience.Left ventricular assist device: a bridge to transplant or destination therapy?Emotional experiences of caregivers of patients with a ventricular assist device.Surgical therapy for heart failure.Reasons for, and outcomes of patients who were referred for a ventricular assist device but were declined: the recent era forgotten ones.The successful implantation of continuous-flow left ventricular assist device as a destination therapy in Korea: echocardiographic assessment.HeartWare miniature axial-flow ventricular assist device: design and initial feasibility test.General and acute care surgical procedures in patients with left ventricular assist devices.Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers.The use of percutaneous ECMO support as a 'bridge to bridge' in heart failure patients: a case report.Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support.A case of conversion of a NIPRO ventricular assist system to an EVAHEART left ventricular assist system.Off-pump insertion of continuous flow left ventricular assist devices.REMATCH and beyond: the cost of treating heart failure using an implantable left ventricular assist device.The current state of left ventricular assist devices: challenges facing further development.Overcoming alterations in body image imposed by the left ventricular assist device: a case report.
P2860
Q28075310-A1913D00-C540-41D4-9825-CC1095D4AA7BQ30226406-7806030C-D100-4D65-B8A5-94F7440AFA7CQ30471684-7B886E06-3A1B-4FDD-A76F-18A0BCD7D762Q35738389-6061B242-3D61-4A73-8FEC-F93E2AD34981Q36597965-17A6870C-49C4-45D6-BCAE-D24A507B4C6AQ36815993-B2877D54-58BB-4AA3-B261-794C19659FC7Q36868932-5317111B-7EFC-425E-919D-8CCDF8679359Q36915732-3F07BD6B-5DAD-4D06-BF5F-15E5F6E2267DQ36932155-35C582CD-9F0B-414E-BA53-FB5A3D274D19Q37067918-92E721E4-D59C-4FBC-95CC-6699FF75A186Q37076282-47A3599C-5027-4C50-8FD5-FCAB4782C73FQ37390760-70B5F500-1F21-4778-9CDB-557971A3EFC1Q38043572-B99ACCB5-8E10-460E-B7E3-9565577B77CBQ38069530-7CF3C2CB-B306-4F77-BA82-9203974E01E8Q38183815-C187A137-24FF-4E51-B05F-FAD31E6340C9Q38371061-CAF17EFA-CCAA-4F3B-B12B-E368CC182433Q38771063-5C61BBC5-BC19-40F3-BA14-1EAB6A73E528Q39855561-52717E39-6F84-4FBA-8D32-E06DAA4FCD34Q40237072-06813D4A-C37B-484A-8D11-DA9B33EB6EB1Q41109533-38EF0068-B59F-4AD0-833F-505490D26B56Q41869325-70868F93-44E0-456E-A3F6-31E9D4C14107Q41875609-04261EEF-A587-4C0D-8824-2C6DB6AF6318Q41965336-C980393F-F3BC-4EFF-8B8F-34B786D2B9B4Q42593572-DFFF9CF7-1BF6-4E0C-B779-FCFA8CD86619Q42969090-BB67D8D8-AB40-4849-98AE-68AAE77E77D9Q43269512-B01781DC-CA92-4386-8871-5E4C8515F6D2Q45114854-8049F782-E24A-46B9-9B93-D0CEC65B55B1Q50948956-D87E4C68-978D-4150-A564-16E00436C044Q51135771-FFAA110A-D43B-4FB4-9309-8856E8B1F349Q51662670-BF58BFF7-7749-43CF-BE89-ECC5B1D4C183Q54482213-AA0EEFF3-437D-4B13-B782-02BBC4884D46
P2860
Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Long-term destination therapy ...... comes since the REMATCH study.
@en
Long-term destination therapy ...... comes since the REMATCH study.
@nl
type
label
Long-term destination therapy ...... comes since the REMATCH study.
@en
Long-term destination therapy ...... comes since the REMATCH study.
@nl
prefLabel
Long-term destination therapy ...... comes since the REMATCH study.
@en
Long-term destination therapy ...... comes since the REMATCH study.
@nl
P2093
P2860
P1476
Long-term destination therapy ...... comes since the REMATCH study.
@en
P2093
Abdallah G Kfoury
Carmelo Milano
James W Long
Joseph Rogers
Marc Silver
Mark S Slaughter
O H Frazier
Reynolds Delgado
P2860
P304
P356
10.1111/J.1527-5299.2005.04540.X
P577
2005-05-01T00:00:00Z